Compare KYMR & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | CPB |
|---|---|---|
| Founded | 2015 | 1869 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.2B |
| IPO Year | 2020 | 1994 |
| Metric | KYMR | CPB |
|---|---|---|
| Price | $80.14 | $20.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 26 | 18 |
| Target Price | ★ $107.72 | $26.06 |
| AVG Volume (30 Days) | 451.5K | ★ 6.5M |
| Earning Date | 04-30-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 7.63% |
| EPS Growth | N/A | ★ 6.35 |
| EPS | N/A | ★ 1.13 |
| Revenue | $39,211,000.00 | ★ $10,253,000,000.00 |
| Revenue This Year | $10.61 | N/A |
| Revenue Next Year | $8.17 | $0.11 |
| P/E Ratio | ★ N/A | $18.21 |
| Revenue Growth | N/A | ★ 6.40 |
| 52 Week Low | $28.33 | $19.56 |
| 52 Week High | $103.00 | $35.00 |
| Indicator | KYMR | CPB |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 42.83 |
| Support Level | $77.71 | $19.90 |
| Resistance Level | $89.80 | $21.46 |
| Average True Range (ATR) | 3.13 | 0.60 |
| MACD | -0.47 | 0.03 |
| Stochastic Oscillator | 25.50 | 33.68 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.